Multiple Sclerosis Clinical Trial

Remote Therapeutic Monitoring Exercise Tracking

Summary

The purpose of this study is to examine physical activity and exercise behaviors in people with Parkinson's Disease and Multiple Sclerosis over the course of 1-year using a cloud-based remote monitoring platform.

View Full Description

Full Description

Remote therapeutic monitoring (RTM) is a reimbursable clinical service. Pilot investigation conducted by our lab demonstrated promise that this service is feasible to add to clinical care. It is unclear still if RTM is able to provide clinical benefit to patients including improving and sustaining physical activity (PA) and exercise behaviors over a longer period of time (>1 year). Our central hypothesis is that the addition of RTM to physical activity, both in a skilled rehabilitation program and within a home program, will improve long term outcomes related to physical activity including self-efficacy for exercise, consistent participation in home exercise recommendations, and quality of life in people living with PD and MS. Thus the specific aims of this study are as follows:

To assess PA and exercise behaviors over 1-year period using a remote therapeutic monitoring platform

a. We will track steps per day, minutes of aerobic activity per week, and frequency of workouts including flexibility, balance, and resistance training.

To understand how engagement with RTM for PA tracking affects overall self-efficacy for exercise, readiness for exercise behavior change, and quality of life.

Assessed through monthly self-report of usability survey for RTM and self-efficacy for exercise survey.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Are ambulatory as their primary means of mobility without an assistive device except for single point cane or walking sticks in community
Have a diagnosis of Parkinson's disease (Hoehn and Yahr 1-3), Parkinsonism, or Multiple Sclerosis
Personal goal and willingness to address physical activity
Have a smart phone (Datos Health app is compatible with any Smart phone device)
Willing to accept Datos' Terms and Conditions

Exclusion Criteria:

Individuals with cognitive or communication disorders (including dementia) which would limit their ability to interact with the RTM

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

200

Study ID:

NCT06306768

Recruitment Status:

Recruiting

Sponsor:

Shirley Ryan AbilityLab

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Shirley Ryan AbilityLab
Chicago Illinois, 60611, United States More Info
Hannah Redd, DPT
Contact
[email protected]
Kristen Hohl, DPT
Contact
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

200

Study ID:

NCT06306768

Recruitment Status:

Recruiting

Sponsor:


Shirley Ryan AbilityLab

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.